Healthcare -
Biotechnology - NASDAQ - US
$ 0.4745
-0.939 %
$ 18.2 M
Market Cap
-0.28
P/E
Price Target
Average
110.75%
Revenue Forecast
Estimate
46.96%
EBIT
Estimate
31.03%
Net Income
Estimate
50.27%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bolt Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for BOLT of $1 , with forecasts ranging from
a
low of
$1 to a high of $1 .
BOLT Lowest Price Target
Wall Street Target
1 USD
110.75%
BOLT Average Price Target
Wall Street Target
1 USD
110.75%
BOLT Highest Price Target
Wall Street Target
1 USD
110.75%
REVENUE FORECAST
Revenue Forecast Chart BOLT
EBIT FORECAST
EBIT Forecast Chart BOLT
NET INCOME FORECAST
Net Income Chart BOLT